Of note, when the systematic review was performed, anti-β2GPI were routinely tested and the studies were performed prior to the latest amendment of the APS classification criteria where anti-β2GPI was included into the criteria. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.